News and Announcements
Imugene Annual Update 2016; Clinical Sites in Asia Opened & New Substantial Shareholder
- Published January 18, 2017 5:24PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Imugene Ltd (ASX: IMU) is an immuno-oncology focused biopharmaceutical company, developing HER-Vaxx, a B Cell peptide vaccine for the treatment of gastric cancer. In no order of importance are listed Imugene’s achievements of 2016;
- A successful capital raising, in doing so bringing on a substantial shareholder in The Platinum Asset Management Fund.
- Opened our clinical sites in Asia and we look forward to enrolling the first cohort of patients.
- Progressed our mimotope discovery platform with the filing of four important patents.
Imugene are proud to have maintained and strengthened their already strong international intellectual property position. Also mentioning the progress made by their scientific team, both at home and abroad in Vienna.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
